Anteilseigner
SUNU Ventures BV (8,70 %) The Vanguard Group, Inc. (7,59 %) BlackRock Fund Advisors (5,43 %) Viking Global Investors LP (4,37 %) Point72 Asset Management LP (4,08 %) Morgan Stanley & Co. LLC (4,02 %) Stonepine Capital Management LLC (3,69 %) Morningside Group Ltd. (3,41 %) Millennium Management LLC (3,35 %) Boxer Capital LLC (3,07 %) Citadel Advisors LLC (2,90 %) Perceptive Advisors LLC (2,76 %) SSgA Funds Management, Inc. (2,13 %) Fidelity Management & Research Co. LLC (2,12 %) Franklin Advisers, Inc. (1,95 %) Jane Street Capital LLC (1,71 %) Eventide Asset Management LLC (1,65 %)
Kontakt
AMYLYX PHARMACEUTICALS INC